Schedule a Consult
 
 
Schedule a Consult

Home / IVF team

Dr. K. D. Nayar

Present Position: Dr. KD Nayar

Presently Chief Consultant Infertility & IVF at Akanksha IVF Centre,since July 2001 in Mata Chanan Devi Hospital, a 225 bedded Superspeciality hospital in South West Delhi. Akanksha IVF Centre was established by me to provide comprehensive facilities for Assisted Reproductive Techniques of International quality control standards, performing about 600 to 700 IVF/ICSI cycles annually.

Area of Expertise : Infertility & IVF

Education and training

Professional Experience

  • 40 Yrs. Experience after Specialization in India & Abroad
  • Chief Consultant & HOD, Akanksha IVF Centre Mata Chanan Devi Hospital, C-1, JanakPuri, New Delhi – 110058 ( 2001 – till date)
  • Chairman, Dept. of Obstetrics and Gynaecology Maternity & Children Hospital, Skaka Kingdom of Saudi Arabia, (1993 – 2001)
  • Consultant &Assist.Head, Dept. of Obstetrics and Gynaecology, Salahuddin University Hospital Tripoli, Libya, (1984 -1991)
  • Medical Officer, Dept. of Obstetrics &Gynaecology, ESI Hospital, Basaidarapur, New Delhi, (1981 -84)

Professional Membership

  • American Society of Reproductive Medicine (ASRM -4586 )
  • European Society of Human Reproduction &Embryology (ESHRE – 16 )
  • Indian Fertility Society (IFS-FM 16)
  • Indian Society for Assisted Reproduction (ISAR-001232 )
  • Asia Pacific Initiative on Reproduction (ASPIRE – 951)
  • Fertility Preservation Society, India (FPS 066)
  • Federation of Obstetricians & Gynecologists of India (FOGSI-ID-20130208)
  • Delhi Medical Council-14778

Program Director

Akanksha IVF Centre Certified Infertility management Courses in Clinical ART & Embryology (Since 2001).

Course Director

Conducting FOGSI Certified Infertility Trainings (Since 2014) Basic & Advanced Infertility Training and IUI

Supervisor

  • One year Diploma Clinical ART, Amity University IFS accredited centre (Since 2015)
  • M.Sc. in Clinical Embryology, Amity University IFS accredited centre (Since 2017)

Current Executive Posts

  • Immediate Past President: Indian Fertility Society 2024-2026
  • Convenor: Education Committee IFS 2018 – 2026
  • Chair Elect: ISIG ASRM 2024-2025

Organizing Secretary

 

  • 12th Annual conference Indian Fertility Society, Lucknow
  • 9th – 11th December 2016
  • 13th Annual conference Indian Fertility Society, New Delhi
  • 8th – 10th December 2017\\

 

 

Scientific Chair

 

  • 16th Annual conference Indian Fertility Society, New Delhi
  • 4th – 6th December 2020
  • 17th Annual conference Indian Fertility Society, New Delhi
  • 10th – 12th December 2021

 

 

Organizing Chair

 

  • 18th Annual Conference Indian Fertility Society, Hyderabad
  • 9th – 11th December 2022
  • 19th – Annual Conference Indian Fertility Society ,New Delhi
  • 8th – 10th December 2023

 

 

Past Executive Posts

  • President: Indian Fertility society (2022-2024)
  • President Elect: Indian Fertility Society (2020 -22)
  • Sr. Vice President: Indian Fertility Society (2018 -20)
  • Secretary General: Indian Fertility Society (2016 -18)
  • Chairman: Infertility committee AOGD (2016-2018)
  • Treasurer: LOC IFFS Conference INDIA (2016)
  • Treasurer: Indian Fertility Society (2010-2016)
  • Member: Infertility Committee AOGD (2014-16)
  • President: Indian Medical Association, JanakPuri Branch (2011-12)
  • Joint Treasurer: Indian Fertility Society (2008-2010)

Reviewer

 

  • ASRM abstracts (Since 2016)
  • Journal of Obstetrics &Gynecology of India (Since 2015)

 

 

Special Interests

Poor Ovarian Responders & recurrent implantation failures.

Chair GDG

Indian Fertility Society Guideline On Poor Ovarian Response-2024

Awards

 

  • ASRM Star Award 2020, 2021, 2022, 2023 & 2024
  • TAPISAR Lifetime achievement AWARD-Nov.2022
  • FOGSI Achiever Award –April 2023
  • IMA Janak puri Lifetime achievement award –July 2023
  • ISAR Lifetime achievement award – Feb. 2024
  • ISSRF Lifetime achievement award – Feb. 2025

 

 

Papers & Posters Presentations

ASRM

Year Place Title
October 23rd-25th 2006. ASRM, New Orleans, USA POSTER “Comparative study of various semen preparation techniques in IUI and their effect on pregnancy”.
October 13th – 17th 2007. Washington POSTER “Sperm cryosurvival using minimal semen volume in test vial”.
November. 8th – 12th 2008. San Francisco, USA Round Table interactive session on “Aromatase inhibitors for enhancing outcome of ART”.
November. 8th – 12th 2008. San Francisco, USA Published: Clomiphene citrate vs. Low dose recombinant FSH for ovarian stimulation in Intra Uterine Insemination cycles for unexplained and male infertility.
October 17th – 21st 2009. Atlanta, USA Round Table interactive session on “Fertility Treatment of PCOS”.
October 25th – 27th 2010. Denver, USA POSTER “A Newer approach for ovarian stimulation in poor responders undergoing
IVF”.
October 15th – 19th, 2011. Orlando, USA POSTER(1)“Does pelvic tuberculosis affect the ovarian reserve and the oocyte in patients undergoing IVF”.

POSTER (2) “Is AFC a better markers then AMH & FSH in predicting the number of oocytes retrieved in women undergoing ovarian stimulation for IVF”.
October14th­- 17th 2013. Boston, USA POSTER (1) “Choosing the right ovulation trigger in Antagonist cycle for an OHSS free clinic

POSTER (2) “Impact of Endometrial injury on successful outcome in IVF cycle”.
October 18th – 22nd2014. Honolulu Hawaii, USA ORAL:“Does Exogenous LH supplementation improve reproductive outcome in poor responder woman undergoing IVF/ICSI in GnRH Antagonist Protocol”.
October 17th– 21st 2015. Baltimore, USA POSTER “Scheduling Hysteroscopic endometrial Biopsy in Endometrial preparation cycles just preceding ET V/S any time in last one year – Does it changes Reproductive outcome.
October 16th – 20th
2016.		 Salt Lake City, USA POSTER(1) “ Affect of GnRH agonist trigger followed by low dose hCG on reproductive outcome in at risk OHSS”.
POSTER(2) “Dysregulated infertility-related genes in women with endometriosis”.
October 28th – 1st November 2017 San Antonio, Texas, USA POSTER (1) Elective frozen Vs. Fresh Embryo transfer in Antagonist cycles in normo-responders: a randomised study.
POSTER (2) Dysregulated gene involved in implantation failure in women with endometriosis.
POSTER (3) Yoga affects IVF outcomes ?
October 6th – 10th  2018 Denver, Colorado
USA		 ORAL “Adjuvant Recombinant LH (rLH) or Growth Hormone (GH) to the Antagonist protocol in poor responders undergoning IVF”
POSTER “ Is time lapse a better option to improve clinical outcome over standard incubator – A case control study”
October 13th – 16th 2019 Philadelphia, Pennsylvania, USA POSTER  “ Assessment of psychological distress in polycystic ovarian syndrome infertile patients at a tertiary level infertility care centre in India”.
October 17th – 21th 2020 Portland, Oregon, USA POSTER (1) Does controlled ovarian hyperstimulation response varies with PCOS phenotypes: A prospective cohort study at a tertiary infertility centre in INDIA.
POSTER(2) Impact of endometriosis on anxiety, depression and quality of life and its association with pregnancy outcomes in infertile patients at a tertiary level infertility centre in INDIA.
October 17th – 20th 2021 Baltimore, Maryland, USA POSTER (1) Single step or sequential media in embryo culture: outcome in donor oocyte cycles
POSTER (2) Comparison of microfluidic sperm sorting (MFSS) versus physiological intracytoplasmic sperm injection (PICSI) versus density gradient in high DNA fragmentation index sperm samples.

POSTER (3) Transdermal oestradiol gel vs oral oestrogen for successful clinical outcome in hormone replacement Frozen embryo transfer (hr-FET) cycles- a prospective randomized controlled study.

POSTER (4) Does dual trigger with combination of gonadotropin-releasing hormone agonist and low dose human chorionic gonadotropin improves clinical outcomes in normal responders in GnRH antagonist IVF- ICSI cycles.
October 24th – 26th 2022 Anaheim,CA, USA POSTER (1) Progesterone primed ovarian stimulation protocol (PPOS) vs GnRh antagonist for patients of freeze all cycles: a prospective randomised controlled trial.
October 14th – 18th 2023 New Orleans, Louisiana, USA “ORAL”
(1) Impact of psychosocial support with meditation on IVF/ICSI clinical outcomes: a prospective cohort study.
(2) Intramural fibroid in infertile women – Experience and Evidence.
October 20th – 23rd 2024 Denver, USA PG Course no. 13
(1) Alternative Stimulation Protocols in Assisted Reproductive Technology.
(2) Complications and Risks in Ovarian Stimulation.
Poster P 322
EFFECTIVENESS OF AUTOLOGOUS PLATELETRICH PLASMA (PRP) THERAPY FOR IMPROVING
ENDOMETRIAL THICKNESS AND PREGNANCY
OUTCOMES IN WOMEN WITH THIN
ENDOMETRIUM : A RANDOMISED
CONTROLLED TRIAL

IFFS

22nd World Congress
September 24th – 28th
2016

23rd World CongressApril 11th to 14th2019

 NCR, New Delhi

Shanghai, China

 Invited Speaker :

  1. Newer advances in Myoma management.

Oral

  1. Consent and counselling.
  2. Role of DHEA supplementation in expected poor responders.
  3. Affect of GnRH agonist trigger followed by low dose hCG on reproductive outcome in at risk OHSS.
  4. Dysregulated infertility related genes in women with endometriosis.

 

Posters:

  1. Clinical outcome of compaction and 8 cells vitrified embryos.
  2. A randomized control study evaluating effectiveness of methylxanthine theophylline in frozen thawed testicular sperm.
  3. Reproductive potential of morphologically poor quality embryos.
  4.  Dual trigger versus single trigger in antagonist IVF cycle.

 

 

Oral

  1. Role of recombinant luteinizing hormone or growth hormone as adjuvants to antagonist protocol in poor responders.
  1. Trigger day progesterone level “A guide towards fresh or frozen transfer and clinical outcome”.

 
24th World Congress September 10th-13th 2023 Athens, Greece Oral
Can adjuvants and rejuvenative therapies increase ovarian reserve?

Invited Expert
Periconceptional Health around the World
25th World Congress April 26th-29th 2025 Tokya, Japan Posters:

Mid-luteal serum progesterone levels and pregnancy outcomes in frozen embryo transfer cycles: a prospective observational study

ART outcomes in poor ovarian responders based on POSEIDON criteria in Indian women: a prospective observational study.

ESHRE

July 3rd -5th2017

 

July 2nd – 4th 2018

June 23rd – 26th 2019

July 5th -8th  2020

26th June-1st  July 2021

 Geneva, Switzerland33rd ESHRE congress

Barcelona, Spain
34th ESHRE congress

Vienna , Austria
35th ESHRE congress

Copenhagen, Denmak
36th ESHRE congress

Paris, France
37th ESHRE congress

 Oral

  1. “Psychological distress of women with primary ovarian insufficiency: effect of counseling training for clinician”.

Poster:

  1. “Dysregulated immune genes and pathways likely contribute to endometriosis-associated infertility”.
  1. “Comparison of fresh versus frozen embryo transfer in women with Polycystic Ovary Syndrome”.

 

Posters:

  1. “Impact of patient’s socioeconomic status on the outcome of IVF cycles in India”.
  1. “Counselling in decision making by couple for Assisted Reproductive Technology – A key role in quality care”.

 

  1. “Psychological influence of azoospermic male infertility diagnosis among men about to start in-vitro fertilization (IVF) treatment using donor sperm”.
  1. “Clinical outcome by using methylxanthine theophylline in frozen thawed testicular sperm in Intra Cytoplasmic Sperm Injection cycles”.

 

  1. “Yoga as an adjuvant to enhance the outcome of IVF treatment”.
  1. “Optimal number of oocyte needed to complete family per retrieval”.

 

 

Oral

  1. To analyze the incidence of ectopic pregnancy in fresh embryo transfer compared to frozen thawed embryo cycle in tertiary care IVF centre in india.

Posters

  1. Outcome of sperm selected by microfluidic technique in high DNA fragmentation index sperm samples.
  1. Randomized control trial of intra uterine infusion of autologous platelet rich plasma (PRP) vs. granulocyte colony stimulating factor (G-CSF) in thin endometrium in frozen embryo transfer.

 

  1. Prevalence of psychological distress in polycystic ovarian syndrome (PCOS) infertile patient and non PCOS infertile controls and their relationship with clinical – biochemical parameters of the syndrome.

 

Posters

  1. Empty follicle syndrome (EFS) in PCOS patients after GnRH agonist trigger at tertiary level infertility centre in INDIA: A prospective cohort study.
  2. Impact of hazardous air quality index in embryo development in an IVF laboratory in New Delhi, INDIA.
  3. Transdermal testosterone vs. oral dehydroepiandrosterone (DHEA)pre-treatment in improving IVF outcomes in diminished ovarian reserve patients (POSEIDON group 3 and 4):                         ` A randomized control trial.
  4. Comparison of letrozolevs. Clomiphine citrate (CC) for ovulation induction in infertile women with polycystic ovarian syndrome (PCOS) in Indian population: A prospective clinical trial.
  5. A prospective randomized control study comparing reproductive outcome of Day5 quarter laser zona thinning assisted hatching (qLZT-AH) in frozen thawed embryo transfers.
  6. Live birth rate of patients where sperm were selected using microfluidic technique in high DNA fragmentation index sperm sample.

Posters

  1. Transdermal testosterone vs. Placebo(lubricant gel) pre-treatment in improving IVF outcomes in diminished ovarian reserve patients (POSEIDON group 3 and 4): a randomised controlled trial.

 

  1. Microfluidic Sperm Sorting (MFSS) technique versus Physiological Intracytoplasmic Sperm Injection (PICSI) technique in high DNA fragmentation index sperm samples.
03rd July-6stJuly 2022

 

25th to28thJune , 2023
Denmark

8th to 10th July, 2024
Amesterdam

 Milan, Italy
38th ESHRE congresss

Copenhangen, Denmark
39th ESHRE Congress

Amesterdam
Netherlands
$0th ESHRE Congress

 Invited Speaker:

Fibroid and fertility- To remove or not to remove debate continues.
Poster

  1. Comparison of Microfluidic Sperm Sorting (MFSS) versus Physiological Intracytoplasmic Sperm Injection (PICSI) versus Density Gradient versus Swim Up in high DNA fragmentation index sperm samples

 

Oral:
Transdrmal testosterone gel (TTG) pre treatment duration in improving ivf outcome in patients with poor prognosis (Poseidon group 3 and 4) : A randomized controlled trial

Poster
The impact of high proportion of immature oocyte in a cohort on the reproductive outcome following ICSI.

 

Invited Speaker:
Ovarian cancer and fertility – Current understanding

Oral :
Ovarian Response Prediction Index(ORPI) as a predictor tool for Ovarian Response and Clinical Pregnancy in IVF/ICSI cycle: A Prespective Cohort Study

Recent Posts